Spike protein binders and neutralisers:

In vitro (laboratory) studies have demonstrated the ability of a wide variety of substances to inhibit the ability of SARS-CoV-2 spike protein to bind to ACE2, thus preventing it from entering cells.

Read more here:  Update published to ‘Treating COVID injection injuries’ (substack.com)